Cells in the Nose Could Act as Entry Points for SARS-CoV-2

  • Author: ChemistryViews.org
  • Published: 30 April 2020
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Nature Medicine/Springer Nature Limited
thumbnail image: Cells in the Nose Could Act as Entry Points for SARS-CoV-2

The coronavirus SARS-CoV-2 causes the current outbreak of the respiratory disease COVID-19. Coronaviruses such as this one have glycoprotein "spikes" on their surface. These spikes help SARS-CoV-2 enter host cells by binding to a receptor on the surface of the host cells' membrane—the angiotensin-converting enzyme 2 (ACE2). In addition to ACE2, the enzyme TMPRSS2 (transmembrane protease serine 2) may also play an important role in SARS-CoV-2 entering cells.


Waradon Sungnak, Wellcome Sanger Institute, Cambridge, UK, and colleagues have investigated the gene expression of ACE2 and TMPRSS2 in different human tissues to find out which types of cells the virus can target. This could have implications for the treatment and prevention of COVID-19. The team used single-cell RNA (scRNA-seq) sequencing results from healthy human subjects, which were generated by the Human Cell Atlas consortium. The investigation included tissues, e.g., from the respiratory system, the eyes, and the gastrointestinal system.


The team found that ACE2 was expressed in low levels in multiple tissues, including in the airways, the eyes, and the gastrointestinal system, but also in the heart and kidneys. The protease TMPRSS2 was expressed in higher levels. This led the team to conclude that the less common ACE2 receptor may be the limiting factor in cell entry for the virus.


The researchers then looked more closely at cells in the airways and found that nasal epithelial cells, including so-called goblet cells and ciliated cells, showed the highest expression of ACE2 in the respiratory system. According to the team, this indicates that these cells could be important for the infection with SARS-CoV-2 and for the transmission of the virus.



Also of Interest

  • Collection: SARS-CoV-2 Virus
    What we know about the new coronavirus and COVID-19
  • LitCovid
    Curated literature hub for tracking up-to-date scientific information about COVID-19
  • Many publishers and other entities have signed a joint statement to ensure that COVID-19 research findings and data are shared rapidly and openly

 

 

Article Views: 1278

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


Magazine of Chemistry Europe (16 European Chemical Societies)published by Wiley-VCH